Výsledky vyhledávání - "F. FEVZI ERSOY"

A UFLC-MS/MS Method for the Simultaneous Analysis of Urinary Podocin and Podocalyxin in Patients with Nephrotic Syndrome

Autor: Mualla Ozcan, Halide Akbas, Gultekin Suleymanlar, Vural Taner Yilmaz, Bahar Akkaya, Bilge Karatoy Erdem, Ramazan Cetinkaya, F. Fevzi Ersoy

Publikováno v: Laboratory Medicine. 53:246-254

Objective To create an efficient and robust mass spectrometric method for the simultaneous quantitation of podocin and podocalyxin in urine samples and to evaluate urinary podocin and podocalyxin levels in patients with nephrotic syndrome (NS). Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31604fef33b255efa58024b34e04e278
https://doi.org/10.1093/labmed/lmab089

Zobrazit plný text záznamu

A case of cyclic hemoperitoneum in a hemodialysis patient: Encapsulated peritoneal sclerosis complicated by endometriosis and fungal peritonitis

Autor: Mustafa Tekinalp Gelen, F. Fevzi Ersoy, Fatih Yılmaz, Ramazan Cetinkaya, Gultekin Suleymanlar, Feyza Bora

Publikováno v: Seminars in Dialysis. 34:176-179

Encapsulated peritoneal sclerosis (EPS) is a rare, but frequently fatal, long-term complication of peritoneal dialysis. Endometriosis is a common gynecological problem but hemoperitoneum due to endometriosis has been reported to be extremely rare in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5103e0e851caa21f14d5b46a8d34e767
https://doi.org/10.1111/sdi.12945

Zobrazit plný text záznamu

Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study

Autor: Cemaliye Kendir, F. Fevzi Ersoy, Yalcin Akdag, Hasan Koc, Hasan Hoser

Publikováno v: International Urology and Nephrology. 51:1261-1270

To evaluate monthly percentage changes of intact parathyroid hormone (iPTH) and other major bone marker levels in patients with secondary hyperparathyroidism (SHPT) undergoing hemodialysis (HD) and receiving paricalcitol.A total of 493 (F/M 244/249)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a042661e3a6a940c4d3afaba4c3998
https://doi.org/10.1007/s11255-019-02175-5

Zobrazit plný text záznamu

P0296LAST HIT ‘' INFECTIONS'’ BROUGHT THE END: CHRONIC KIDNEY DISEASE TO RENAL REPLACEMENT TREATMENT

Autor: F. Fevzi Ersoy, Emine Asar, Ümit Çakmak, Fatih Yılmaz, Gultekin Suleymanlar, Feyza Bora

Publikováno v: Nephrology Dialysis Transplantation. 35

Background and Aims It is evident that Chronic Kidney Disease (CKD) influences the risk of developing AKI (Acute Kidney Injury) and recent studies suggest that CKD patients who experienced an episode of AKI are more likely to progress to end stage re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2859a274b17476921da86c7bb97468b1
https://doi.org/10.1093/ndt/gfaa142.p0296

Zobrazit plný text záznamu

P1304FIBROBLAST GROWTH FACTOR (FGF23) AND CARDIOVASCULAR MORTALITY IN DIALYSIS PATIENTS: A 10 YEAR PROSPECTIVE SINGLE CENTER STUDY

Autor: F. Fevzi Ersoy, Sabahat Ozdem, Gülay Demirtaş, Üstün Yılmaz, Sadan Turgut, Gultekin Suleymanlar

Publikováno v: Nephrology Dialysis Transplantation. 35

Background and Aims The aim of the study is to evaluate whether circulating fibroblast growth factor 23 (FGF23) predicts cardiovascular mortality in dialysis patients, independent of markers of calcium-phosphate metabolism and cardiovascular risk fac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::803c8d6a8e3e227742435573ae7dd96b
https://doi.org/10.1093/ndt/gfaa142.p1304

Zobrazit plný text záznamu

Serum uromodulin levels, MR imaging findings, and their relationship with eGFR-based CKD staging in ADPKD patients

Autor: Funda Sari, Gultekin Suleymanlar, Can Çevikol, Hale Nur Cansever, F. Fevzi Ersoy, Ramazan Cetinkaya

Publikováno v: International urology and nephrology. 53(7)

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease that may progress to end-stage renal disease, characterized by increased kidney volume due to cystic formations. In this study, we aimed to investigate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7aca537648ac8790c155d0acd989b49
https://pubmed.ncbi.nlm.nih.gov/33389516

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání